In the study done by McNamara and co-workers, even though the first generation prostrate specific membrane antigen (PSMA) aptamer/ polo-like kinase 1(Plk1)-siRNA (A10-Plk1) chimera inhibited tumor growth, it lacked the ability to be systemically administered (McNamara et al., 2006). This evidence concerns the gene PLK1 and neoplasm.